Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and ...
CV Sciences Inc. Annual cash flow by MarketWatch. View CVSI net cash flow, operating cash flow, operating expenses and cash dividends.
Revenue: Fourth-quarter revenues decreased 1% year-over-year; full year 2025 revenues increased 7%. Operating Cash Flow: Generated the highest annual operating cash flow in company history; full year ...
EBITDA Recurring Savings: Achieved $200 million in 2025, with further savings expected in 2026. Free Cash Flow from Operations: Reached $1.4 billion in 2025 with a 46% conversion rate. Net Income: ...
Financing cash flow was -386.39 million MXN in the latest quarter, changing by -425.44% compared to the previous quarter. What was Nutrisa SA de CV’s levered free cash flow in the latest quarter?
Financing cash flow was -650.43 in the latest quarter, changing by 17.90% compared to the previous quarter. What was Grupo Gicsa SA de CV’s levered free cash flow in the latest quarter? Levered free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results